… Among atrial fibrillation (AF) patients who … on dabigatran or rivaroxaban. Drug use was
also reported by dose for patients on the full drug dose (dabigatran 150 mg BID and rivaroxaban …

… dabigatran and rivaroxaban in atrial fibrillation patients. … Rivaroxaban therapy was associated
with a statistically … death compared with dabigatran therapy in atrial fibrillation patients. …

… a higher proportion of rivaroxaban than dabigatran users to be treated with the lower
dose, which was present in our data, with 19.6% of dabigatran- and 26.8% of rivaroxaban-treated …

Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …

… efficacy between dabigatran 150 … atrial fibrillation. It appears however that apixaban is
associated with less major bleeding than dabigatran 150 mg or rivaroxaban and that rivaroxaban …

… methods, we compared outcome rates with rivaroxaban to outcome rates with dabigatran
and warfarin We found similar or lower stroke rates with rivaroxaban, but higher a mortality …

… NVAF patients initiating dabigatran or rivaroxaban were matched with up to 5 warfarin users.
Propensity score-adjusted Cox regression was used to calculate hazard ratios (HR) and 95…

… and meta-analysis, rivaroxaban was as effective as dabigatran, but was more … atrial fibrillation
patients. Major bleeding risk was significantly higher with rivaroxaban than with dabigatran…

… with nonvalvular atrial fibrillation who were users of apixaban, dabigatran, rivaroxaban,
or … (n=15 390), dabigatran versus warfarin (n=28 614), and rivaroxaban versus warfarin (n=32 …

… of dabigatran, rivaroxaban, and … rivaroxaban and dabigatran at a dose of 150 mg,10, 12,
13 whereas our study demonstrated a higher bleeding risk with rivaroxaban than with dabigatran…